ZNTL - Zentalis Pharmaceuticals, Inc.
4.05
-0.200 -4.938%
Share volume: 1,180,353
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$4.25
-0.20
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-09-2024 | 11-12-2024 | 03-26-2025 | 05-14-2025 | 11-10-2025 | 03-26-2026 | |
| Assets | ||||||||
| Total Assets | 557.479 M | 491.680 M | 450.661 M | 430.337 M | 384.021 M | 327.250 M | 288.967 M | |
| Current Assets | 503.806 M | 439.616 M | 400.270 M | 386.066 M | 342.882 M | 288.302 M | 253.191 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 451.368 M | 389.409 M | 349.932 M | 337.183 M | 290.524 M | 241.625 M | 209.898 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 37.616 M | 36.976 M | 41.320 M | 33.901 M | 41.929 M | 39.072 M | 35.995 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.679 M | 5.337 M | 5.016 M | 4.699 M | 3.247 M | 2.927 M | 2.770 M | |
| Other Assets | 47.994 M | 46.727 M | 45.375 M | 39.572 M | 37.892 M | 36.021 M | 33.006 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 557.479 M | 491.680 M | 450.661 M | 430.337 M | 384.021 M | 327.250 M | 288.967 M | |
| Total liabilities | 98.708 M | 109.099 M | 96.330 M | 93.151 M | 88.639 M | 74.376 M | 72.763 M | |
| Total current liabilities | 54.798 M | 66.692 M | 54.877 M | 52.725 M | 49.430 M | 37.168 M | 36.559 M | |
| Accounts Payable | 10.502 M | 20.440 M | 8.202 M | 7.438 M | 7.769 M | 7.031 M | 7.208 M | |
| Other liabilities | 43.910 M | 42.407 M | 41.453 M | 40.426 M | 39.209 M | 37.208 M | 36.204 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 43.910 M | 42.407 M | 41.453 M | 40.426 M | 39.209 M | 37.208 M | 36.204 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 458.771 M | 382.581 M | 354.331 M | 337.186 M | 295.382 M | 252.874 M | 216.204 M | |
| Common stock | 1.336 B | 1.349 B | 1.360 B | 1.391 B | 1.398 B | 1.409 B | 1.407 B | |
| Retained earnings | -878.488 M | -966.765 M | -1.007 B | -1.054 B | -1.103 B | -1.156 B | -1.191 B |